- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03834818
Collecting Outcomes and Managing Pain After Surgery (COMPAS)
June 26, 2024 updated by: Duke University
COMPAS Trial. Collecting Outcomes and Managing Pain After Surgery: Predicting Patients at High Risk for Chronic Opioid Use and Creating Algorithms to Responsibly Tailor Opioid Prescribing and Weaning After Surgery
The primary aim of this study is to measure pain and psychosocial patient reported outcomes, objective functionality, and actual daily at home opioid usage in orthopedic patients.
The study's goal following the data collection is to predict which patients are at high risk for chronic opioid use.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
10000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ashley Burke
- Phone Number: +1 919 681 2849
- Email: ashley.burke@duke.edu
Study Contact Backup
- Name: Michael Bullock, MD
- Phone Number: +1 919 668 2024
- Email: william.bullock@duke.edu
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke Orthopaedics
-
Contact:
- Neil D Ray, MD
- Phone Number: 919-681-1924
- Email: neil.d.ray@duke.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- aged 18-90 years old who are undergoing elective orthopedic surgery at Duke Health.
- Patients must have their own smartphone IOS or Android device.
- Patients must be able to read English.
Exclusion Criteria:
- Lacking capacity to provide consent.
- Cannot read English
- Under 18 years of age
- Older than 90 years of age
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: COMPAS Participants
Patents between the ages of 18 and 90 who are undergoing orthopedic surgery at Duke Health will be eligible for enrollment.
|
The schedule of events for this study are as follows: Day 1 Pre-Surgery:
Every Day
Outcome Surveys and Active Task:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reported Pain of Participants measured via PROMIS-29
Time Frame: 6 Months
|
28 Questions regarding pain are ranked on a 5-point Likert Scale with 1 meaning "not at all" and 5 meaning "very much".
|
6 Months
|
Reported Pain of Participants measured via PROMIS-29
Time Frame: 6 Months
|
One question on an 11-point rating scale for pain intensity, with 0 meaning "no pain" and 10 meaning "worst imaginable pain".
|
6 Months
|
Reported Pain of Participants measured via Pain Catastrophizing pain scale.
Time Frame: 6 Months
|
Statements regarding pain are rated on a scale from 0 to 4 with 0 meaning "not at all" and 4 meaning "all the time"
|
6 Months
|
Opioid Use of Participants
Time Frame: 6 months
|
Total number of patients with self reported use of opioids.
|
6 months
|
Practicality of Mobile Application
Time Frame: 6 Months
|
How long participants actively use the app to track their opined use and pain.
|
6 Months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Michael Bullock, MD, Duke University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
January 1, 2025
Primary Completion (Estimated)
April 1, 2026
Study Completion (Estimated)
April 1, 2026
Study Registration Dates
First Submitted
February 6, 2019
First Submitted That Met QC Criteria
February 6, 2019
First Posted (Actual)
February 8, 2019
Study Record Updates
Last Update Posted (Actual)
June 27, 2024
Last Update Submitted That Met QC Criteria
June 26, 2024
Last Verified
June 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Pro00094157
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgery
-
3MRecruitingAbdominal Surgery | Orthopedic Surgery | Vascular Surgery | Cardiovascular SurgeryUnited States
-
Vanderbilt UniversityCompletedHand Surgery | Wrist Surgery | Forearm Surgery | Elbow SurgeryUnited States
-
Nantes University HospitalCompletedGynecological Surgery | Plastic Surgery | ENT SurgeryFrance
-
Edwards LifesciencesCompletedAbdominal Surgery | Pelvic Surgery | Non-Cardiac/ Non-Thoracic Surgery | Major Peripheral Vascular SurgeryUnited States
-
Maquet Cardiopulmonary GmbHNAMSARecruitingCardiac Surgery | Cardiopulmonary Bypass | Thoracic Surgery | Vascular SurgerySpain
-
Baylor Research InstituteChiesi USA, Inc.RecruitingSurgery | Cardiac Surgery | Surgery--Complications | Percutaneous Coronary InterventionUnited States
-
Vanderbilt UniversityEdwards LifesciencesCompletedCardiac Surgery | Thoracic Surgery | Heart Surgery | Heart Transplant
-
Poudre Valley Health SystemTerminatedSurgery | Surgery--ComplicationsUnited States
-
EgymedicalpediaCompletedSurgery | Pediatric SurgeryEgypt
-
Cairo UniversityBatterjee Medical College; Taif UniversityCompletedSurgery | Bariatric SurgeryEgypt, Saudi Arabia
Clinical Trials on COMPAS Participants
-
Alliance for International Medical ActionHarvard School of Public Health (HSPH); University of Bordeaux, INSERM, Bordeaux...CompletedAcute Malnutrition in Infancy (Disorder)Niger
-
University of Colorado, DenverNational Center for Advancing Translational Sciences (NCATS); Colorado Clinical...Completed
-
Brittany L SmallsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingDiabetes Mellitus, Type 2United States
-
Petros DinasEuropean CommissionCompleted
-
University of MinnesotaCompleted
-
GE HealthcareQuintiles, Inc.; H2O Clinical LLCCompletedParkinson's Disease | Essential TremorUnited States
-
Northwestern UniversityWashington University School of MedicineRecruiting
-
University of Colorado, DenverNational Institute of Nursing Research (NINR)CompletedHeart Failure | Cancer | COPDUnited States
-
The Leeds Teaching Hospitals NHS TrustRecruitingChlamydia | GonorrheaUnited Kingdom
-
University of FloridaUniversity of California, Los Angeles; National Ataxia FoundationRecruitingSpinocerebellar Ataxia Type 3 | Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 6United States